"Fatty Liver, Alcoholic" - Books

Result Filters

See GYS2 (LIVER) glycogen synthase 2 in the Gene database

liver in Camelus dromedarius (3)All 3 Gene records

Results: 1 to 20 of 246 books (1041 items)

<< First< Prev

Page of 13

Next >Last >>

Select item 44036681.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Top results in this book Table of Contents

Select item 42928302.

Non-Alcoholic Fatty Liver Disease: Assessment and Management.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 49.)

Top results in this book Table of Contents

Select item 48538163.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 34012944.

Endotext [Internet].

Feingold KR, Anawalt B, Blackman MR, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

Top results in this book Table of Contents

Select item 29557345.

Insulin Sensitisers in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review.

Shyangdan D, Clar C, Ghouri N, et al.

Southampton (UK): NIHR Journals Library; 2011 Nov. (Health Technology Assessment, No. 15.38.)

Top results in this book Table of Contents

Select item 26591826.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Top results in this book Table of Contents

Select item 42913847.

Cirrhosis in Over 16s: Assessment and Management.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 50.)

Top results in this book Table of Contents

Select item 55113628.

Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.

Bresnahan R, Duarte R, Mahon J, et al.

Southampton (UK): National Institute for Health and Care Research; 2023 Jul. (Health Technology Assessment, No. 27.10.)

Top results in this book Table of Contents

Select item 33895669.

Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.

Crossan C, Tsochatzis EA, Longworth L, et al.

Southampton (UK): NIHR Journals Library; 2015 Jan. (Health Technology Assessment, No. 19.9.)

Top results in this book Table of Contents

Select item 317235610.

Diet and Health: Implications for Reducing Chronic Disease Risk.

National Research Council (US) Committee on Diet and Health.

Washington (DC): National Academies Press (US); 1989.

Top results in this book Table of Contents

Select item 145898411.

GeneReviews® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2024.

Top results in this book Table of Contents

Select item 456505012.

Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT.

Selby PJ, Banks RE, Gregory W, et al.

Southampton (UK): NIHR Journals Library; 2018 Jun. (Programme Grants for Applied Research, No. 6.3.)

Top results in this book Table of Contents

Select item 332735413.

Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study.

Lilford RJ, Bentham L, Girling A, et al.

Southampton (UK): NIHR Journals Library; 2013 Jul. (Health Technology Assessment, No. 17.28.)

Top results in this book Table of Contents

Select item 487112814.

Hepatocellular Carcinoma [Internet].

Tirnitz-Parker JEE, editor.

Brisbane (AU): Codon Publications; 2019 Oct 24.

Top results in this book Table of Contents

Select item 292188615.

Non-Invasive Diagnostic Assessment Tools for the Detection of Liver Fibrosis in Patients with Suspected Alcohol-Related Liver Disease: A Systematic Review and Economic Evaluation.

Stevenson M, Lloyd-Jones M, Morgan MY, et al.

Southampton (UK): NIHR Journals Library; 2012 Feb. (Health Technology Assessment, No. 16.4.)

Top results in this book Table of Contents

Select item 413219816.

Alcohol Consumption and Ethyl Carbamate.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

Lyon (FR): International Agency for Research on Cancer; 2010. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 96.)

Top results in this book Table of Contents

Select item 242389617.

Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet].

Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-.

Top results in this book Table of Contents

Select item 493301218.

Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet].

Hoshida Y, editor.

Cham (CH): Humana Press; 2019.

Top results in this book Table of Contents

Select item 256931019.

NIHR Health Technology Assessment programme: Executive Summaries.

Southampton (UK): NIHR Journals Library; 2003-.

Top results in this book Table of Contents

Select item 518941020.

Liver Cancer [Internet].

Sergi CM, editor.

Brisbane (AU): Exon Publications; 2021 Apr 6.

Top results in this book Table of Contents

<< First< Prev

Page of 13

Next >Last >>

Supplemental Content

Images search in Bookshelf

Figure 1.Main causes of hepatic iron damage in thalassaemia. NAFLD, non-alcoholic fatty liver disease; ALD, alcoholic liver disease; HBV, hepatitis B virus; HCV, hepatitis C virus.

LIVER DISEASE.

Cappellini MD, Cohen A, Porter J, et al., editors. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT) [Internet]. 3rd edition. Nicosia (CY): Thalassaemia International Federation; 2014.
Figure 1Overview of fatty liver disease

(A) Image obtained from a human liver biopsy stained with hematoxylin and eosin. The circular “holes” in the sample image correspond to lipid droplets (steatosis). (B) General progression of fatty liver diseases. NAFLD, alcoholic liver disease, and hepatitis C mediated by HCV/HBV are all thought to progress through similar etiologies, initiating with excessive lipid droplet formation within the hepatocytes (steatosis), which progresses to damage to the hepatocytes (steatohepatitis) and fibrosis, cirrhosis and development of hepatocellular carcinoma.

Potent inhibitors of lipid droplet formation.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
FIGURE 41

Chronic liver disease. ALD, alcoholic liver disease; ALT, alanine transaminase; AST, aspartate transaminase; CH, chronic hepatitis; FN, false negative; FP, false positive; HBV, chronic hepatitis B virus; HCV, chronic hepatitis C virus; NAFLD, non-alcoholic fatty liver disease; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis; TN, true negative; TP, true positive.

Forest plots of sensitivity and specificity per diagnostic indicator.

Elwenspoek MMC, Thom H, Sheppard AL, et al. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Southampton (UK): National Institute for Health and Care Research; 2022 Oct.